These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 31630275)
101. Liver cancer and hepatic decompensation events in patients hospitalized with viral hepatitis in Spain. Ramos-Rincon JM; Pinargote-Celorio H; de Mendoza C; Ramos-Belinchón C; Barreiro P; Treviño A; Corral O; Soriano V Hepatol Int; 2022 Oct; 16(5):1161-1169. PubMed ID: 35666390 [TBL] [Abstract][Full Text] [Related]
102. Hepatitis C virus and other risk factors in hepatocellular carcinoma. Schiefelbein E; Zekri AR; Newton DW; Soliman GA; Banerjee M; Hung ChW; Seifeldin IA; Lo AC; Soliman AS Acta Virol; 2012; 56(3):235-40. PubMed ID: 23043603 [TBL] [Abstract][Full Text] [Related]
103. Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Welzel TM; Graubard BI; Quraishi S; Zeuzem S; Davila JA; El-Serag HB; McGlynn KA Am J Gastroenterol; 2013 Aug; 108(8):1314-21. PubMed ID: 23752878 [TBL] [Abstract][Full Text] [Related]
104. Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era. MacDonald DC; Nelson M; Bower M; Powles T World J Gastroenterol; 2008 Mar; 14(11):1657-63. PubMed ID: 18350596 [TBL] [Abstract][Full Text] [Related]
105. Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide. Maucort-Boulch D; de Martel C; Franceschi S; Plummer M Int J Cancer; 2018 Jun; 142(12):2471-2477. PubMed ID: 29388206 [TBL] [Abstract][Full Text] [Related]
106. The impact of background liver disease on the long-term prognosis of very-early-stage HCC after ablation therapy. Takaura K; Kurosaki M; Inada K; Kirino S; Yamashita K; Muto T; Osawa L; Sekiguchi S; Hayakawa Y; Higuchi M; Kaneko S; Maeyashiki C; Tamaki N; Yasui Y; Itakura J; Tsuchiya K; Nakanishi H; Takahashi Y; Izumi N PLoS One; 2022; 17(2):e0264075. PubMed ID: 35196341 [TBL] [Abstract][Full Text] [Related]
107. Epidemiology, clinical features, and impact of food habits on the risk of hepatocellular carcinoma: A case-control study in Bangladesh. Shawon MA; Yousuf MAK; Raheem E; Ahmed S; Dipti TT; Hoque MR; Taniguchi H; Karim MR PLoS One; 2020; 15(4):e0232121. PubMed ID: 32339207 [TBL] [Abstract][Full Text] [Related]
108. Hepatitis C virus attributable liver cancer in the country of Georgia, 2015-2019: a case-control study. Surguladze S; Armstrong PA; Beckett GA; Shadaker S; Gamkrelidze A; Tsereteli M; Getia V; Asamoah BO BMC Infect Dis; 2024 Sep; 24(1):1045. PubMed ID: 39333949 [TBL] [Abstract][Full Text] [Related]
109. Death certificates compared to SEER-Medicare data for surveillance of liver cancer mortality due to hepatitis B or hepatitis C infection. Jiang JJ; Shiels MS; O'Brien TR J Viral Hepat; 2021 Jun; 28(6):934-941. PubMed ID: 33720473 [TBL] [Abstract][Full Text] [Related]
110. Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and C. Duffell E; Cortez-Pinto H; Simonova M; Dalgard O; Dahl EH; de Martel C; Mozalevskis A; Buti M; Pavlova S; Hadzhilova T; Simões C; Katzarov K; Mardh O J Viral Hepat; 2021 Aug; 28(8):1177-1189. PubMed ID: 34003542 [TBL] [Abstract][Full Text] [Related]
111. 8 years post-marketing surveillance between Asari Radix and hepatocellular carcinoma: Nationwide population-based evidence against an association. Chen CN; Tsai YT; Lai JN J Ethnopharmacol; 2019 Oct; 243():112094. PubMed ID: 31323301 [TBL] [Abstract][Full Text] [Related]
112. The changing pattern of epidemiology in hepatocellular carcinoma. Nordenstedt H; White DL; El-Serag HB Dig Liver Dis; 2010 Jul; 42 Suppl 3(Suppl 3):S206-14. PubMed ID: 20547305 [TBL] [Abstract][Full Text] [Related]
113. Hepatocellular carcinoma in patients coinfected with hepatitis B or C and HIV: more aggressive tumor behavior? Saud LRC; Chagas AL; Maccali C; Pinto PVA; Horvat N; Alencar RSSM; Tani CM; Abdala E; Carrilho FJ Eur J Gastroenterol Hepatol; 2021 Apr; 33(4):583-588. PubMed ID: 33560682 [TBL] [Abstract][Full Text] [Related]
114. New horizons in hepatitis B and C in the older adult. Kemp L; Clare KE; Brennan PN; Dillon JF Age Ageing; 2019 Jan; 48(1):32-37. PubMed ID: 30379991 [TBL] [Abstract][Full Text] [Related]
115. International trends in hepatocellular carcinoma incidence, 1978-2012. Petrick JL; Florio AA; Znaor A; Ruggieri D; Laversanne M; Alvarez CS; Ferlay J; Valery PC; Bray F; McGlynn KA Int J Cancer; 2020 Jul; 147(2):317-330. PubMed ID: 31597196 [TBL] [Abstract][Full Text] [Related]
116. Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Chuang SC; La Vecchia C; Boffetta P Cancer Lett; 2009 Dec; 286(1):9-14. PubMed ID: 19091458 [TBL] [Abstract][Full Text] [Related]
117. Epidemiology of hepatocellular carcinoma and its viral risk factors. Kew MC Acta Gastroenterol Belg; 2000; 63(2):227-9. PubMed ID: 10925474 [No Abstract] [Full Text] [Related]
118. Managing patients with hepatitis‑B-related or hepatitis‑C-related decompensated cirrhosis. Fink SA; Jacobson IM Nat Rev Gastroenterol Hepatol; 2011 May; 8(5):285-95. PubMed ID: 21695841 [TBL] [Abstract][Full Text] [Related]
119. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Venook AP; Papandreou C; Furuse J; de Guevara LL Oncologist; 2010; 15 Suppl 4():5-13. PubMed ID: 21115576 [TBL] [Abstract][Full Text] [Related]
120. Multiple pregnancies, hepatitis C, and risk for hepatocellular carcinoma in Egyptian women. Amr S; Iarocci EA; Nasr GR; Saleh D; Blancato J; Shetty K; Loffredo CA BMC Cancer; 2014 Nov; 14():893. PubMed ID: 25432765 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]